GLP-1 clinical trials enrolling now. Find one near you.

179 GLP-1 clinical trials covering 123 conditions are recruiting across 48 US states as of October 2, 2026. You pay nothing for the medication.

In every clinical trial here, the study medication and trial visits cost you nothing, and many pay you for your time. Some participants get a placebo, assigned at random.

Filters

Condition

State

Phase

Sponsor

Screening for a study can take weeks. The cheapest program today is Strut Health.

No insurance needed.

Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →You pick Weight Loss, then a five-minute online visit
Shed$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan

179 of 179 clinical trials match

Weight-loss studies (39)

Weight-loss study of cagrisema

Where: Texas, California and 28 more states

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.

Free to join

Who can join: Adults 18+ with obesity, BMI 35+.

Sites and phone numbers Study record on ClinicalTrials.gov

Weight-loss study of orforglipron

Where: Texas, California and 27 more states

What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.

Free to join

Who can join: Children and teens 6 to 17 with obesity.

Sites and phone numbers Study record on ClinicalTrials.gov

Weight-loss study of semaglutide

Where: Florida, Texas and 14 more states

What: Tests whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help people lose weight.

Free to join

Who can join: Adults 18+ who are overweight.

Sites and phone numbers Study record on ClinicalTrials.gov

Type 2 diabetes studies (13)

Type 2 diabetes study of survodutide

Where: Florida, Texas and 29 more states

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Sites and phone numbers Study record on ClinicalTrials.gov

Type 2 diabetes study of semaglutide

Where: Texas, California and 28 more states

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Sites and phone numbers Study record on ClinicalTrials.gov

Type 2 diabetes study of cagrisema

Where: Texas, California and 15 more states

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 25+.

Sites and phone numbers Study record on ClinicalTrials.gov

Other GLP-1 studies (127)

Fatty liver disease with liver scarring study of survodutide

Where: Texas, Florida and 28 more states

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).

Sites and phone numbers Study record on ClinicalTrials.gov

Fatty liver disease (MASLD) study of retatrutide

Where: Texas, Florida and 33 more states

What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.

Sites and phone numbers Study record on ClinicalTrials.gov

Fatty liver disease (also called MASH or NASH) study of survodutide

Where: Florida, Texas and 23 more states

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.

Sites and phone numbers Study record on ClinicalTrials.gov

Not sure which clinical trial fits you? Answer no more than 8 short questions, one per screen. We show you the clinical trials that fit your age, where you live, and the rules each one sets.

Take the quiz →

Get an email when a trial opens near you

New GLP-1 clinical trials open every month. Tell us your state and we email you when one starts recruiting near you. The medication costs you nothing, and some pay you for your time.

How this directory works

The data comes from ClinicalTrials.gov, the US federal registry for clinical research. We pull active and pre-active GLP-1 clinical trials (semaglutide, tirzepatide, liraglutide, retatrutide, survodutide, orforglipron, cagrisema and related molecules) plus studies of GLP-1 effects on conditions like obesity, type 2 diabetes, MASH, sleep apnea, CKD, and cardiovascular disease.

Every Monday we check these listings against ClinicalTrials.gov. Before you contact a site, click through to its registry record and confirm the clinical trial is still recruiting. For the wider picture on getting a GLP-1 at no cost, see how to get a GLP-1 for free.

How to enroll in a clinical trial

Find a clinical trial below or take the matching quiz. Read the eligibility criteria. The key inclusion and exclusion items are the ones the trial coordinator will check first.
Find a site location near you. We list every US site with city, state, and contact information when the sponsor publishes it.
Contact the site directly using the phone or email on the trial page. Tell them you read about the trial on GLP Chart and you want to be screened.
Screening typically involves a phone call, a clinic visit, and sometimes blood work. Most clinical trials cover the cost of screening and trial-related medical care. Some sites compensate participants for their time; the trial coordinator explains what each site offers.
If you do not qualify for the trial you contacted, ask the site coordinator about other clinical trials they run. Many sites run multiple GLP-1 studies at once and can route you to a better fit.

If a trial is not a fit and you need treatment now, the GLP-1 cost guide lays out what every legitimate cash-pay path costs at maintenance dose.

A few legal notes

GLP Chart is not affiliated with any of the sponsors or sites listed. We do not enroll patients in clinical trials, and we are not paid for clinical-trial referrals. If that changes, this page will say so on the day it does.

Participating in a clinical trial is a serious medical decision. Talk to your existing healthcare provider before enrolling. Trial coordinators are required by federal regulation to walk you through informed consent before you join.

GLP-1 clinical trials by state

1714 recruiting sites across 48 states. The number beside each state is how many studies are enrolling there.

53 more studies have not opened enrollment

ClinicalTrials.gov lists these as not yet recruiting. Open a study's registry record to see whether the sponsor has posted a start date.

Eli Lilly and Company, obesity, phase 3. NCT07817875 on ClinicalTrials.gov
Eli Lilly and Company, diabetes mellitus type 2, phase 3. NCT07668336 on ClinicalTrials.gov
Boehringer Ingelheim, obesity, phase 3. NCT07850063 on ClinicalTrials.gov
Novo Nordisk A/S, obesity, phase 3. NCT07400107 on ClinicalTrials.gov
Boehringer Ingelheim, obesity, phase 3. NCT07855900 on ClinicalTrials.gov
Boehringer Ingelheim, obesity, phase 3. NCT07850050 on ClinicalTrials.gov
Pfizer, obesity, phase 3. NCT07845500 on ClinicalTrials.gov
Biomed Industries, Inc, obesity and overweight, phase 2. NCT06732245 on ClinicalTrials.gov
Massachusetts General Hospital, obesity, phase 4. NCT07729332 on ClinicalTrials.gov
University of Colorado, Denver, obesity/therapy, phase 3. NCT07021937 on ClinicalTrials.gov
University of Virginia, obesity & overweight, phase 3. NCT07298915 on ClinicalTrials.gov
The Methodist Hospital Research Institute, endometrial atypical hyperplasia, phase 2. NCT07820358 on ClinicalTrials.gov
Novo Nordisk A/S, overweight, phase 1. NCT07855133 on ClinicalTrials.gov
University of Texas Southwestern Medical Center, methamphetamine use disorder, phase 2. NCT07825857 on ClinicalTrials.gov
Washington University School of Medicine, lower back pain, phase 2. NCT07731256 on ClinicalTrials.gov
Vanderbilt University Medical Center, type 2 diabetes mellitus (t 2 DM), phase 2. NCT07760948 on ClinicalTrials.gov
National Cancer Institute (NCI), endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia, phase 2. NCT07349641 on ClinicalTrials.gov
University of Massachusetts, Worcester, gestational diabetes mellitus (GDM), phase 2. NCT07797036 on ClinicalTrials.gov
University of North Carolina, Chapel Hill, pouch ileal, phase 4. NCT07756359 on ClinicalTrials.gov
The Cleveland Clinic, COPD, phase 2. NCT07747805 on ClinicalTrials.gov
Johns Hopkins University, alcohol use disorder, phase 2. NCT07249554 on ClinicalTrials.gov
Children's Hospital Medical Center, Cincinnati, stage 1 diabetes mellitus type 1, phase 2. NCT07430332 on ClinicalTrials.gov
Indiana University, obesity & overweight, phase 2. NCT07823452 on ClinicalTrials.gov
Noom Inc, obesity & overweight. NCT07588984 on ClinicalTrials.gov
UNC Lineberger Comprehensive Cancer Center, endometrial cancer, phase 2. NCT07078838 on ClinicalTrials.gov
Stanford University, prediabetes / type 2 diabetes, phase 4. NCT06682351 on ClinicalTrials.gov
Mayo Clinic, genetic predisposition, phase 2. NCT06972407 on ClinicalTrials.gov
University of Minnesota, obesity childhood, phase 4. NCT06977438 on ClinicalTrials.gov
Baylor Research Institute, chronic kidney disease, phase 4. NCT07547878 on ClinicalTrials.gov
William Marsh Rice University, GLP-1, phase 4. NCT07554417 on ClinicalTrials.gov
Jing Luo, obesity & overweight, phase 4. NCT07832084 on ClinicalTrials.gov
Goldman, Butterwick, Fitzpatrick and Groff, laxity skin, phase 2. NCT07217743 on ClinicalTrials.gov
Children's Hospital Medical Center, Cincinnati, autism spectrum disorder, phase 4. NCT07770152 on ClinicalTrials.gov
Goldman, Butterwick, Fitzpatrick and Groff, wrinkle, phase 2. NCT07221461 on ClinicalTrials.gov
Ali Aminian, atrial fibrillation, phase 4. NCT07027969 on ClinicalTrials.gov
Ponsky Facial Aesthetics And Plastic Surgery, Llc, facial skin aging. NCT07760532 on ClinicalTrials.gov
Mayo Clinic, anatomic stage i breast cancer AJCC v 8, phase 4. NCT07769047 on ClinicalTrials.gov
Yale University, alcohol use disorder (AUD), phase 1. NCT07772960 on ClinicalTrials.gov
Milton S. Hershey Medical Center, grade 1 endometrial endometrioid carcinoma, phase 1. NCT07812636 on ClinicalTrials.gov
University of Wisconsin, Madison, GLP-1, phase 1. NCT07758231 on ClinicalTrials.gov
Hartford HealthCare, lower urinary tract symptoms. NCT07175805 on ClinicalTrials.gov
Pennington Biomedical Research Center, obesity. NCT07796204 on ClinicalTrials.gov
Louisiana State University and A&M College, women's health. NCT07787533 on ClinicalTrials.gov
University of Alabama at Birmingham, weight loss. NCT07535892 on ClinicalTrials.gov
University of Chicago, lung cancer, phase 1. NCT07782359 on ClinicalTrials.gov
Vanderbilt University Medical Center, duchenne muscular dystrophy (DMD), phase 1. NCT07642635 on ClinicalTrials.gov
Oelisoa Andriankaja, obesity. NCT07478653 on ClinicalTrials.gov
The Cleveland Clinic, type 2 diabetes. NCT07695454 on ClinicalTrials.gov
Banner Health, prostate cancer, phase 1. NCT07727473 on ClinicalTrials.gov
The Cleveland Clinic, diabetes. NCT07784127 on ClinicalTrials.gov
Tufts University, weight maintenance. NCT07701460 on ClinicalTrials.gov
Goldman, Butterwick, Fitzpatrick and Groff, laxity skin. NCT07558603 on ClinicalTrials.gov
University of California, San Francisco, weight management. NCT07829016 on ClinicalTrials.gov

Written and edited by John SamarasAbout this site Contact

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.